MIGUEL ÁNGEL
GALLO MEZO
Investigador en el periodo 2002-2017
Publicaciones en las que colabora con MIGUEL ÁNGEL GALLO MEZO (29)
2018
-
Thiadiazoline- And pyrazoline-based carboxamides and carbothioamides: Synthesis and inhibition against nitric oxide synthase
Journal of Chemistry, Vol. 2018
2016
-
Quinazolinones, Quinazolinthiones, and Quinazolinimines as Nitric Oxide Synthase Inhibitors: Synthetic Study and Biological Evaluation
Archiv der Pharmazie, pp. 638-650
2013
-
Antiproliferative activity, cell cycle, and apoptosis studies of a series of 6-substituted 9H-purin-9-yl-pyridinium derivatives on a human cervical carcinoma cell line
ChemMedChem, Vol. 8, Núm. 8, pp. 1266-1269
2012
-
The selective cytotoxic activity in breast cancer cells by an anthranilic alcohol-derived acyclic 5-fluorouracil O,N-acetal is mediated by endoplasmic reticulum stress-induced apoptosis
European Journal of Medicinal Chemistry, Vol. 50, pp. 376-382
2011
-
Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5- tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine
European Journal of Medicinal Chemistry, Vol. 46, Núm. 9, pp. 3802-3809
2008
-
Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies
Bioorganic and Medicinal Chemistry Letters, Vol. 18, Núm. 4, pp. 1457-1460
-
Design, synthesis and anticancer activity against the MCF-7 cell line of benzo-fused 1,4-dihetero seven- and six-membered tethered pyrimidines and purines
Current Medicinal Chemistry, Vol. 15, Núm. 25, pp. 2614-2631
-
From 5-fluorouracil acyclonucleosides to benzo-fused six- and seven-membered rings linked to pyrimidine and purine bases: The shift from differentiating anticancer agents to apoptotic inducers
Expert Opinion on Drug Discovery, Vol. 3, Núm. 10, pp. 1223-1235
-
Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin- 3-ylmethyl)-9H-purines
ChemMedChem, Vol. 3, Núm. 1, pp. 127-135
2007
-
5-fluorouracil derivatives induce differentiation mediated by tubulin and HLA class I modulation
Medicinal Chemistry, Vol. 3, Núm. 3, pp. 233-239
-
A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells
Breast Cancer Research and Treatment, Vol. 105, Núm. 3, pp. 237-246
-
Corrigendum to "Synthesis and reactivity of (RS)-6-chloro-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)-7H- or 9H-purines bearing a nitrobenzenesulfonyl group on the nitrogen atom". [Tetrahedron 63 (2007) 5274] (DOI:10.1016/j.tet.2007.03.155)
Tetrahedron
-
QSAR as a tool for the development of potent antiproliferative agents by inhibition of choline kinase
Current Computer-Aided Drug Design, Vol. 3, Núm. 4, pp. 297-313
-
Synthesis and reactivity of (RS)-6-chloro-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)-7H- or 9H-purines bearing a nitrobenzenesulfonyl group on the nitrogen atom
Tetrahedron, Vol. 63, Núm. 24, pp. 5274-5286
2006
-
(Q)SAR studies to design new human choline kinase inhibitors as antiproliferative drugs
Current Medicinal Chemistry, Vol. 13, Núm. 11, pp. 1231-1248
-
Study of the factors that control the ratio of the products between 5-fluorouracil, uracil, and tetrahydrobenzoxazepine O,O-acetals bearing electron-withdrawing groups on the nitrogen atom
Journal of Organic Chemistry, Vol. 71, Núm. 3, pp. 1043-1054
-
Synthesis and anticancer activity studies of novel 1-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)uracil and (6′-substituted)-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or 9H-purines
Tetrahedron, Vol. 62, Núm. 50, pp. 11724-11733
2005
-
1H and 13C spectral assignment of symmetrical bis[(4-aminosubstituted)quinolinium] derivatives
Magnetic Resonance in Chemistry, Vol. 43, Núm. 12, pp. 1066-1071
-
Symmetrical bis-quinolinium compounds: New human choline kinase inhibitors with antiproliferative activity against the HT-29 cell line
Journal of Medicinal Chemistry, Vol. 48, Núm. 9, pp. 3354-3363
-
Towards a model for the inhibition of choline kinase by a new type of inhibitor
European Journal of Medicinal Chemistry, Vol. 40, Núm. 3, pp. 315-319